For example, inhibiting the expression of transient receptor potential channel 5 (TRPC5) can weaken the ABCB1 efferent pump by inhibiting the Wnt/β-catenin signaling pathway, thus reversing 5-FU resistance in CRC [31]. The gene discussed is TRPC5; the disease is colorectal carcinoma.